Stay updated with breaking news from Bryan Wahl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight brokerages that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has received an average recommendation of “Moderate Buy” from the eight analysts that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month price objective among brokerages […]
Abrdn plc purchased a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 72,032 shares of the company’s stock, valued at approximately $1,459,000. Several other hedge funds have also recently made changes to their positions in TARS. RTW Investments LP boosted its position […]
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight research firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month […]
Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) posted its earnings results on Tuesday. The company reported ($1.31) earnings per share for the quarter, beating the consensus estimate of ($1.37) by $0.06, MarketWatch Earnings reports. The company had revenue of $13.08 million for the quarter, compared to analysts’ expectations of $4.63 million. During the same period […]